Clinical Trials Directory

Trials / Completed

CompletedNCT06040060

Ketamine Effects as Preemptive Analgesia

Effects of Ketamine 0.5 Mg/Kgbw Administration as Preemptive Analgesia on Analgesia Duration and the Need for Fentanyl Following Hysterectomy Surgery

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Universitas Padjadjaran · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The goal of this randomized controlled trial is to compare the effect of preemptive ketamine administration to placebo administration in patients underwent hysterectomy surgery. The main questions it aims to answer are: 1. To determine the effect of ketamine at a dose of 0.5 mg/kgBW as preemptive analgesia on the duration of analgesia after hysterectomy surgery 2. To determine the effect of ketamine at a dose of 0.5 mg/kgBW as preemptive analgesia on the need for fentanyl after hysterectomy surgery

Conditions

Interventions

TypeNameDescription
DRUGKetamineThe intervention was prepared by the research team (anesthesia resident) in the form of ketamine which had been diluted to a dosage of 10 mg/cc, taken according to the required dose based on actual body weight then diluted with 0.9% NaCl to 10 cc. Then the two solutions were given to researchers without knowing the contents of the drugs that had been prepared by the resident who assisted in this research.
OTHERPlaceboWhile the 0.9% NaCl solution was used as placebo was prepared in a 10 cc syringe

Timeline

Start date
2022-12-27
Primary completion
2023-03-03
Completion
2023-03-03
First posted
2023-09-15
Last updated
2023-09-22

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT06040060. Inclusion in this directory is not an endorsement.